Research · Normal Labs, Still Unwell
Functional vs Standard Ranges
How lab ranges are made, where evidence has moved the line, and what "optimal" ranges can and can't tell you.
If your blood work came back "normal" but you still feel unwell, you may have heard that "functional" or "optimal" ranges would catch what the standard ones miss.
A standard reference range describes the middle 95% of results from a group of healthy people. It is a description of health, not a judgment about outcomes.1,2 "Functional" or "optimal" ranges are narrower bands, promoted mostly in functional medicine and direct-to-consumer testing. We found no published studies that validate the commercial versions against health outcomes, and a 2026 review describes the evidence for functional medicine's testing model as limited.3 For some tests, though, research has set decision limits that differ from the reference range, such as HbA1c for diabetes and ferritin for iron deficiency. Those limits come from outcome and diagnostic studies, not from the word "optimal."4
How standard lab ranges are made
The middle 95% of healthy people
The international guideline for laboratories (CLSI EP28) recommends measuring at least 120 carefully chosen healthy people and taking the 2.5th and 97.5th percentiles as the limits.1,2 Two things follow:
- About 1 in 20 healthy people falls outside the range on any one test. The more tests, the more of these false flags. If 10 independent tests are run on a healthy person, the chance that all come back normal is only about 60%; with 15 tests it is about 46%.5 (That calculation assumes the tests are independent, so treat it as an illustration.)
- Ranges depend on who was measured. A global study of 13,386 healthy adults in 12 countries found differences between countries in nearly half of the tests, and differences by sex and age were common.6,7 For vitamin B12, which runs higher in people of Black ethnic origin, reference ranges come mainly from white populations.2
So a standard range tells you whether a result is unusual for healthy people, not whether it is ideal for you. Normal labs, still unwell? covers what that means for symptoms.
Reference ranges vs decision limits
Where evidence has moved the line
Laboratory medicine already separates two ideas. A reference range describes healthy people. A clinical decision limit is a cut-off tied to the risk of a bad outcome, and it can sit well inside or outside the reference range.4 As one paper put it, reference ranges cannot replace decision limits.5
| Test | Decision limit | Where it comes from |
|---|---|---|
| HbA1c (average blood sugar) | Diabetes at 6.5% (48 mmol/mol) or above; prediabetes at 5.7–6.4%8 | Rates of diabetic eye disease in about 28,000 people in nine countries9 |
| LDL cholesterol | At 190 mg/dL (4.9 mmol/L) or above, U.S. guidelines start high-intensity statins without a risk calculation; lower thresholds apply to people at very high risk10 | Cardiovascular outcome trials, reviewed by the guideline panel |
| Ferritin (iron stores) | Iron deficiency below 15 µg/L in healthy people aged 5 and over, and below 70 µg/L in adults with infection or inflammation (WHO)11; 45 ng/mL in people with anemia (American Gastroenterological Association)12 | Studies of how well each cut-off finds true iron deficiency |
Ferritin shows how much the cut-off matters. In 62 people with anemia, a cut-off of 12 µg/L caught only 25% of those who were iron-deficient, while 30 µg/L caught 92%, with 98% specificity.13 (µg/L and ng/mL are the same unit.) This is the kind of evidence a narrower range needs: a study showing that the new line finds real disease or predicts real outcomes.
Where the experts still disagree
Thyroid and vitamin D
- TSH (thyroid). In 14,333 Americans without known thyroid disease, 85% had a TSH below 2.5 mIU/L. Lowering the upper limit to 2.5 would label about 9.7% more people, some 20.6 million Americans, as abnormal. The authors found no reported benefit from treating people in that band.14 Others argued that more than 95% of healthy people sit below 2.5 and proposed 0.4–2.5 as an "optimal" range.15,16 The debate is unresolved.
- Vitamin D. In 2011 the Institute of Medicine concluded that a blood level of 20 ng/mL (50 nmol/L) meets the needs of at least 97.5% of people.17 The Endocrine Society's 2011 guideline treated 30 ng/mL as "sufficiency."18 In 2024 the Endocrine Society stopped endorsing that 30 ng/mL target and advised against routine vitamin D testing in the general population.19,20
What about "functional" and "optimal" ranges?
Narrower, but not validated
We could not find a peer-reviewed source that explains how the commercial functional ranges sold with lab panels were derived, or a study testing them against health outcomes. A 2026 review in the American Journal of Medicine describes functional medicine's reliance on "nonstandard laboratory testing" and says that evidence validating it as a distinct diagnostic model "remains limited."3 A 2025 review warns that direct-to-consumer testing risks turning healthy people into patients.21
Research on outcome-based "sweet spots" does exist, and it is early. In 30,097 Canadian adults, 94 of 231 measurements showed a range linked to healthier aging, generally narrower than the reference range.22 That study is observational and measured people at one point in time, so its sweet spots are leads for research, not targets for treatment.
Describes healthy people
The middle 95% of a measured healthy group. Says whether a result is unusual, not whether it is ideal.
Narrower, usually unvalidated
Promoted as where the body works best. We found no published outcome studies behind the commercial versions.
The cost of narrower ranges
More flags, more follow-up
- Overuse is common. A meta-analysis estimated that about 20.6% of lab tests are ordered when they are not needed.23
- Cascades. In a national survey, 99.4% of U.S. internists had seen a cascade of further tests and treatment after an incidental finding. They reported psychological harm to patients (68.4%), physical harm (15.6%) and financial burden (57.5%).24
- Direct-to-consumer panels. An analysis of 76 panels sold in the U.S. and Europe rated 58.1% of their 191 tests as low-value or likely to set off cascades; the largest panel would produce an expected 9.8 false positives per healthy buyer.25 (Two of the four authors are from Labplus R&D rather than a university, and the two raters agreed less often than the study had planned, so treat the exact figures with care.)
Questions to ask about a result
Useful whether a result is in range or not
Classical East Asian medicine reads the same person through patterns rather than numbers; see What is a TCM pattern?
Quick answers
What are functional lab ranges?
Narrower ranges than the lab's standard ones, promoted as where the body works best. They are used mainly in functional medicine and direct-to-consumer testing. We found no published studies validating the commercial versions against health outcomes.
What is the functional range for ferritin?
There is no validated "functional" ferritin range. Evidence-based cut-offs depend on context: WHO uses 15 µg/L in healthy people and 70 µg/L in adults with inflammation, and gastroenterologists use 45 ng/mL in people with anemia. Talk to your clinician before taking iron.
What is the optimal TSH range?
Some experts proposed 0.4–2.5 mIU/L, and others argued the standard range should stay. The debate is unresolved, and there is no evidence that treating TSH values between 2.5 and the standard upper limit helps.
Are functional ranges evidence-based?
Not the commercial versions, as far as we could find. Where evidence has supported a different cut-off, as for HbA1c, LDL cholesterol and ferritin, it came from outcome or diagnostic studies, and those cut-offs are already used in mainstream medicine.
Why do different labs give different ranges?
Labs use different methods and different reference groups, and ranges vary with age, sex and population. Compare a result with the range printed on the same report.
Sources
- Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, Third Edition (EP28-A3c). Wayne, PA: CLSI; 2008 (corrected 2010). clsi.org
- Timbrell NE. The role and limitations of the reference interval within clinical chemistry and its reliability for disease detection. British Journal of Biomedical Science. 2024;81:12339. doi:10.3389/bjbs.2024.12339. PubMed
- Soffer GK, et al. Drawing a line between integrative and functional medicine. American Journal of Medicine. 2026 (online ahead of print). doi:10.1016/j.amjmed.2026.08.021. PubMed
- Ozarda Y, et al. Distinguishing reference intervals and clinical decision limits: A review by the IFCC Committee on Reference Intervals and Decision Limits. Critical Reviews in Clinical Laboratory Sciences. 2018;55(6):420–431. doi:10.1080/10408363.2018.1482256. PubMed
- Jørgensen LG, et al. Should we maintain the 95 percent reference intervals in the era of wellness testing? A concept paper. Clinical Chemistry and Laboratory Medicine. 2004;42(7):747–751. doi:10.1515/CCLM.2004.126. PubMed
- Ichihara K, et al. A global multicenter study on reference values: 1. Assessment of methods for derivation and comparison of reference intervals. Clinica Chimica Acta. 2017;467:70–82. doi:10.1016/j.cca.2016.09.016. PubMed
- Ichihara K, et al. A global multicenter study on reference values: 2. Exploration of sources of variation across the countries. Clinica Chimica Acta. 2017;467:83–97. doi:10.1016/j.cca.2016.09.015. PubMed
- American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes, 2026. Diabetes Care. 2026;49(Suppl 1):S27–S49. doi:10.2337/dc26-S002. PubMed
- International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327–1334. doi:10.2337/dc09-9033. PubMed
- Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082–e1143. doi:10.1161/CIR.0000000000000625. PubMed
- World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: WHO; 2020. PubMed
- Ko CW, et al. AGA clinical practice guidelines on the gastrointestinal evaluation of iron deficiency anemia. Gastroenterology. 2020;159(3):1085–1094. doi:10.1053/j.gastro.2020.06.046. PubMed
- Mast AE, et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clinical Chemistry. 1998;44(1):45–51. doi:10.1093/clinchem/44.1.45. PubMed
- Surks MI, et al. The thyrotropin reference range should remain unchanged. Journal of Clinical Endocrinology and Metabolism. 2005;90(9):5489–5496. doi:10.1210/jc.2005-0170. PubMed
- Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. Journal of Clinical Endocrinology and Metabolism. 2005;90(9):5483–5488. doi:10.1210/jc.2005-0455. PubMed
- Dickey RA, et al. Optimal thyrotropin level: Normal ranges and reference intervals are not equivalent. Thyroid. 2005;15(9):1035–1039. doi:10.1089/thy.2005.15.1035. PubMed
- Ross AC, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. Journal of Clinical Endocrinology and Metabolism. 2011;96(1):53–58. doi:10.1210/jc.2010-2704. PubMed
- Holick MF, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2011;96(7):1911–1930. doi:10.1210/jc.2011-0385. PubMed
- Demay MB, et al. Vitamin D for the prevention of disease: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2024;109(8):1907–1947. doi:10.1210/clinem/dgae290. PubMed
- McCartney CR, et al. Vitamin D insufficiency and epistemic humility: An Endocrine Society guideline communication. Journal of Clinical Endocrinology and Metabolism. 2024;109(8):1948–1954. doi:10.1210/clinem/dgae322. PubMed
- Orth M, et al. Direct-to-consumer testing: Benefits and concerns of commercially accessed laboratory tests. Clinical Chemistry. 2025;71(6):652–663. doi:10.1093/clinchem/hvaf004. PubMed
- Vishnyakova O, et al. Physiological phenotypes have optimal values relevant to healthy aging: Sweet spots deduced from the Canadian Longitudinal Study on Aging. GeroScience. 2024;46(2):1589–1605. doi:10.1007/s11357-023-00895-2. PubMed
- Zhi M, et al. The landscape of inappropriate laboratory testing: A 15-year meta-analysis. PLoS One. 2013;8(11):e78962. doi:10.1371/journal.pone.0078962. PubMed
- Ganguli I, et al. Cascades of care after incidental findings in a US national survey of physicians. JAMA Network Open. 2019;2(10):e1913325. doi:10.1001/jamanetworkopen.2019.13325. PubMed
- Agrawal S, et al. Clinical utility and harm potential of direct-to-consumer laboratory test panels: A cross-sectional content analysis across commercial providers in the United States and Europe. Clinical Chemistry and Laboratory Medicine. 2026;64(11):2419–2429. doi:10.1515/cclm-2026-0679. PubMed
This article is for education only and is not medical advice. See our Medical Disclaimer. Last reviewed October 13, 2026.
Research Worth Reading
New articles like this one, sent to you when they are published: what the evidence actually shows and what the classical texts actually say, in plain English. Join The Naturalist Archive and you will also hear first about Archive giveaways, and receive the English translation of Nam Dược Thần Hiệu free the day it is released.